Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Publications

Publications searcher

The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points.

Peri-operative treatment of anaemia in major orthopaedic surgery: a practical approach from Spain.

PMID: 28151388
Journal: Blood Transfusion
Year: 2017
Reference: Blood Transfus. 2017 Jul;15(4):296-306. doi: 10.2450/2017.0177-16. Epub 2017 Jan 26.
Impact factor: 1.607
Publication type: Review in national publication
Authors: Bisbe, Elvira, Basora, Misericordia, Colomina, Maria J et al.
DOI: 10.2450/2017.0177-16

Peri-operative treatment of anaemia in major orthopaedic surgery: a practical approach from Spain.

PMID: 28151388
Journal: Blood Transfusion
Year: 2017
Reference: Blood Transfus. 2017 Jul;15(4):296-306. doi: 10.2450/2017.0177-16. Epub 2017 Jan 26.
Impact factor:
Publication type: Review in national publication
Authors: Basora, Misericordia; Bisbe, Elvira; Colomina, Maria J et al.
DOI: 10.2450/2017.0177-16

Peripheral levels of BDNF and opiate-use disorder: literature review and update.

PMID: 28306543
Journal: REVIEWS IN THE NEUROSCIENCES
Year: 2017
Reference: Rev Neurosci. 2017 Jul 26;28(5):499-508. doi: 10.1515/revneuro-2016-0078.
Impact factor: 2.546
Publication type: Review in international publication
Authors: Palma-Alvarez, Raul Felipe, Ros-Cucurull, Elena, Amaro-Hosey, Kristopher, Rodriguez-Cintas, Laia, Grau-Lopez, Lara, Corominas-Roso, Margarida, Sanchez-Mora, Cristina, Roncero, Carlos et al.
DOI: 10.1515/revneuro-2016-0078

Peripheral levels of BDNF and opiate-use disorder: literature review and update.

PMID: 28306543
Journal: REVIEWS IN THE NEUROSCIENCES
Year: 2017
Reference: Rev Neurosci. 2017 Jul 26;28(5):499-508. doi: 10.1515/revneuro-2016-0078.
Impact factor:
Publication type: Review in international publication
Authors: Amaro-Hosey, Kristopher; Corominas-Roso, Margarida; Grau-Lopez, Lara; Palma-Alvarez, Raul Felipe; Palma-Alvarez, Raul Felipe; Rodriguez-Cintas, Laia; Roncero, Carlos; Ros-Cucurull, Elena; Sanchez-Mora, Cristina et al.
DOI: 10.1515/revneuro-2016-0078

Peripheral nervous system involvement in multiple sclerosis.

PMID: 28185471
Journal: Multiple Sclerosis Journal
Year: 2017
Reference: Mult Scler. 2017 Apr;23(5):751. doi: 10.1177/1352458517693469. Epub 2017 Feb 10.
Impact factor: 4.84
Publication type: Review in international publication
Authors: Rovira, Alex et al.
DOI: 10.1177/1352458517693469

Peripheral nervous system involvement in multiple sclerosis.

PMID: 28185471
Journal: Multiple Sclerosis Journal
Year: 2017
Reference: Mult Scler. 2017 Apr;23(5):751. doi: 10.1177/1352458517693469. Epub 2017 Feb 10.
Impact factor:
Publication type: Review in international publication
Authors: Rovira, Alex et al.
DOI: 10.1177/1352458517693469

Periprosthetic joint infection by Propionibacterium acnes: Clinical differences between monomicrobial versus polymicrobial infection.

PMID: 28285096
Journal: ANAEROBE
Year: 2017
Reference: Anaerobe. 2017 Apr;44:143-149. doi: 10.1016/j.anaerobe.2017.03.008. Epub 2017 Mar 8.
Impact factor: 2.278
Publication type: Paper in international publication
Authors: Gomez, Lucia, Matamala, A, Lung, Mayli, Cuchi, Eva, Corona, Pablo S, Muneton, David, Figa, Raul et al.
DOI: 10.1016/j.anaerobe.2017.03.008

Periprosthetic joint infection by Propionibacterium acnes: Clinical differences between monomicrobial versus polymicrobial infection.

PMID: 28285096
Journal: ANAEROBE
Year: 2017
Reference: Anaerobe. 2017 Apr;44:143-149. doi: 10.1016/j.anaerobe.2017.03.008. Epub 2017 Mar 8.
Impact factor:
Publication type: Paper in international publication
Authors: Corona, Pablo S; Cuchi, Eva; Figa, Raul; Gomez, Lucia; Lung, Mayli; Matamala, A; Muneton, David et al.
DOI: 10.1016/j.anaerobe.2017.03.008

Pharmacogenetics of methylphenidate response and tolerability in attention-deficit/hyperactivity disorder.

PMID: 26810137
Journal: PHARMACOGENOMICS JOURNAL
Year: 2017
Reference: Pharmacogenomics J. 2017 Jan;17(1):98-104. doi: 10.1038/tpj.2015.89. Epub 2016 Jan 26.
Impact factor: 3.815
Publication type: Paper in international publication
Authors: Pagerols, M, Richarte, V, Sanchez-Mora, C, Garcia-Martinez, I, Corrales, M, Corominas, M, Cormand, B, Ribases, M, Ramos-Quiroga, J A, Casas, M et al.
DOI: 10.1038/tpj.2015.89

Pharmacogenetics of methylphenidate response and tolerability in attention-deficit/hyperactivity disorder.

PMID: 26810137
Journal: PHARMACOGENOMICS JOURNAL
Year: 2017
Reference: Pharmacogenomics J. 2017 Jan;17(1):98-104. doi: 10.1038/tpj.2015.89. Epub 2016 Jan 26.
Impact factor:
Publication type: Paper in international publication
Authors: Casas, M; Cormand, B; Corominas, M; Corrales, M; Garcia-Martinez, I; Pagerols, M; Ramos-Quiroga, J A; Ribases, M; Richarte, V; Sanchez-Mora, C et al.
DOI: 10.1038/tpj.2015.89

PHARMACOKINETIC AND TISSUE DISTRIBUTION OF BENZNIDAZOLE AFTER ORAL ADMINISTRATION IN MICE.

PMID: 28167558
Journal: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Year: 2017
Reference: Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: AAC.02410-16. doi: 10.1128/AAC.02410-16. Print 2017 Apr.
Impact factor: 4.302
Publication type: Paper in international publication
Authors: Perin, Luisa, Moreira da Silva, Rodrigo, da Silva Fonseca, Katia, Mirelle de Oliveira Cardoso, Jamille, Mathias, Fernando Augusto Siqueira, Reis, Levi Eduardo Soares, Molina, Israel, Correa-Oliveira, Rodrigo, de Abreu Vieira, Paula Melo, Carneiro, Claudia Martins et al.
DOI: 10.1128/AAC.02410-16

PHARMACOKINETIC AND TISSUE DISTRIBUTION OF BENZNIDAZOLE AFTER ORAL ADMINISTRATION IN MICE.

PMID: 28167558
Journal: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Year: 2017
Reference: Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: AAC.02410-16. doi: 10.1128/AAC.02410-16. Print 2017 Apr.
Impact factor:
Publication type: Paper in international publication
Authors: Carneiro, Claudia Martins; Correa-Oliveira, Rodrigo; da Silva Fonseca, Katia; de Abreu Vieira, Paula Melo; Mathias, Fernando Augusto Siqueira; Mirelle de Oliveira Cardoso, Jamille; Molina, Israel; Moreira da Silva, Rodrigo; Perin, Luisa; Reis, Levi Eduardo Soares et al.
DOI: 10.1128/AAC.02410-16

Pharmacokinetic of benznidazole in healthy volunteers: Implications in future clinical trials.

PMID: 28167552
Journal: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Year: 2017
Reference: Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: AAC.01912-16. doi: 10.1128/AAC.01912-16. Print 2017 Apr.
Impact factor: 4.302
Publication type: Paper in international publication
Authors: Pedraz, J L, Pinto, L, Esquisabel, A, Perin, L, Molina, I, Salvador, F, Sanchez-Montalva, A, Artaza, M A, Moreno, R et al.
DOI: 10.1128/AAC.01912-16

Pharmacokinetic of benznidazole in healthy volunteers: Implications in future clinical trials.

PMID: 28167552
Journal: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
Year: 2017
Reference: Antimicrob Agents Chemother. 2017 Mar 24;61(4). pii: AAC.01912-16. doi: 10.1128/AAC.01912-16. Print 2017 Apr.
Impact factor:
Publication type: Paper in international publication
Authors: Artaza, M A; Esquisabel, A; Molina, I; Moreno, R; Pedraz, J L; Perin, L; Pinto, L; Salvador, F; Sanchez-Montalva, A et al.
DOI: 10.1128/AAC.01912-16

Pharmacokinetic/Pharmacodynamic Modeling for Drug Development in Oncology.

PMID: 28561730
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annua
Year: 2017
Reference: Am Soc Clin Oncol Educ Book. 2017;37:210-215. doi: 10.1200/EDBK_180460.
Impact factor: 0
Publication type: Editorail in international publication
Authors: Garralda, Elena, Dienstmann, Rodrigo, Tabernero, Josep et al.
DOI: 10.1200/EDBK_180460

Pharmacokinetic/Pharmacodynamic Modeling for Drug Development in Oncology.

PMID: 28561730
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annua
Year: 2017
Reference: Am Soc Clin Oncol Educ Book. 2017;37:210-215. doi: 10.1200/EDBK_180460.
Impact factor:
Publication type: Editorail in international publication
Authors: Dienstmann, Rodrigo; Garralda, Elena; Tabernero, Josep et al.
DOI: 10.1200/EDBK_180460

Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the standardized collection of a minimum set of data.

PMID: 28045651
Journal: Farmacia hospitalaria : organo oficial de expresio
Year: 2017
Reference: Farm Hosp. 2017 Jan 1;41(n01):31-48. doi: 10.7399/fh.2017.41.1.10463.
Impact factor: 0
Publication type: Paper in international publication
Authors: Calleja Hernandez, Miguel Angel, Herrero Ambrosio, Alicia, Lamas Diaz, Maria Jesus, Martinez Cutillas, Julio, Aragon, Belen, Poveda Andres, Jose Luis et al.
DOI: 10.7399/fh.2017.41.1.10463

Pharmacotherapy follow-up of patients under treatment with biologic agents for chronic inflammatory systemic conditions: an agreement among hospital pharmacists for the standardized collection of a minimum set of data.

PMID: 28045651
Journal: Farmacia hospitalaria : organo oficial de expresio
Year: 2017
Reference: Farm Hosp. 2017 Jan 1;41(n01):31-48. doi: 10.7399/fh.2017.41.1.10463.
Impact factor:
Publication type: Paper in international publication
Authors: Aragon, Belen; Calleja Hernandez, Miguel Angel; Herrero Ambrosio, Alicia; Lamas Diaz, Maria Jesus; Martinez Cutillas, Julio; Poveda Andres, Jose Luis et al.
DOI: 10.7399/fh.2017.41.1.10463

Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity.

PMID: 28600476
Journal: CLINICAL CANCER RESEARCH
Year: 2017
Reference: Clin Cancer Res. 2017 Sep 15;23(18):5406-5415. doi: 10.1158/1078-0432.CCR-17-0812. Epub 2017 Jun 9.
Impact factor: 9.619
Publication type: Paper in international publication
Authors: Thomas, Marlene, Meulendijks, Didier, Jacob, Wolfgang, Voest, Emile E, Mau-Sorensen, Morten, Martinez-Garcia, Maria, Taus, Alvaro, Fleitas, Tania, Cervantes, Andres, Lolkema, Martijn P et al.
DOI: 10.1158/1078-0432.CCR-17-0812

Phase Ib Study of Lumretuzumab Plus Cetuximab or Erlotinib in Solid Tumor Patients and Evaluation of HER3 and Heregulin as Potential Biomarkers of Clinical Activity.

PMID: 28600476
Journal: CLINICAL CANCER RESEARCH
Year: 2017
Reference: Clin Cancer Res. 2017 Sep 15;23(18):5406-5415. doi: 10.1158/1078-0432.CCR-17-0812. Epub 2017 Jun 9.
Impact factor:
Publication type: Paper in international publication
Authors: Adessi, Celine; Bossenmaier, Birgit; Calles, Antonio; Ceppi, Maurizio; Cervantes, Andres; De Jonge, Maja J; Dua, Rajiv; Felip, Enriqueta; Fleitas, Tania; Han, Ji-Youn et al.
DOI: 10.1158/1078-0432.CCR-17-0812

Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH).

PMID: 28609226
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2017
Reference: J Clin Oncol. 2017 Aug 20;35(24):2781-2789. doi: 10.1200/JCO.2016.71.9476. Epub 2017 Jun 13.
Impact factor: 24.008
Publication type: Paper in international publication
Authors: Peters, Solange, Gettinger, Scott, Johnson, Melissa L, Janne, Pasi A, Garassino, Marina C, Christoph, Daniel, Toh, Chee Keong, Rizvi, Naiyer A, Chaft, Jamie E, Carcereny Costa, Enric et al.
DOI: 10.1200/JCO.2016.71.9476

Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH).

PMID: 28609226
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2017
Reference: J Clin Oncol. 2017 Aug 20;35(24):2781-2789. doi: 10.1200/JCO.2016.71.9476. Epub 2017 Jun 13.
Impact factor:
Publication type: Paper in international publication
Authors: Carcereny Costa, Enric; Chaft, Jamie E; Chow, Laura Q M; Christoph, Daniel; Felip, Enriqueta; Fruh, Martin; Garassino, Marina C; Gettinger, Scott; Ho, Cheryl; Janne, Pasi A et al.
DOI: 10.1200/JCO.2016.71.9476

Phase III Study Comparing a Reduced Dose of Cabazitaxel (20 mg/m(2)) and the Currently Approved Dose (25 mg/m(2)) in Postdocetaxel Patients With Metastatic Castration-Resistant Prostate Cancer-PROSELICA.

PMID: 28809610
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2017
Reference: J Clin Oncol. 2017 Oct 1;35(28):3198-3206. doi: 10.1200/JCO.2016.72.1076. Epub 2017 Aug 15.
Impact factor: 24.008
Publication type: Paper in international publication
Authors: Zhang, Wenping, Bernard, John, de Bono, Johann, Chadjaa, Mustapha, Kacso, Gabriel, Font, Albert, Parente, Phillip, Eisenberger, Mario, Hardy-Bessard, Anne-Claire, Kim, Choung Soo et al.
DOI: 10.1200/JCO.2016.72.1076

Phase III Study Comparing a Reduced Dose of Cabazitaxel (20 mg/m(2)) and the Currently Approved Dose (25 mg/m(2)) in Postdocetaxel Patients With Metastatic Castration-Resistant Prostate Cancer-PROSELICA.

PMID: 28809610
Journal: JOURNAL OF CLINICAL ONCOLOGY
Year: 2017
Reference: J Clin Oncol. 2017 Oct 1;35(28):3198-3206. doi: 10.1200/JCO.2016.72.1076. Epub 2017 Aug 15.
Impact factor:
Publication type: Paper in international publication
Authors: Bernard, John; Carles, Joan; Chadjaa, Mustapha; de Bono, Johann; Eisenberger, Mario; Font, Albert; Ford, Daniel; Geczi, Lajos; Hardy-Bessard, Anne-Claire; Kacso, Gabriel et al.
DOI: 10.1200/JCO.2016.72.1076